Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

61. Coronavirus (COVID-19) Infection in Pregnancy

Coronavirus (COVID-19) Infection in Pregnancy 1 Information for healthcare professionals Version 1: Published Monday 9 March, 2020 Coronavirus (COVID-19) Infection in Pregnancy2 Table of contents Introduction 3-5 Advice for health professionals to share with pregnant women 7-9 Advice for services caring for women with suspected or confirmed COVID-19 11-23 Advice for services caring for women following recovery from confirmed COVID-19 25 Acknowledgements 26 Flow chart to assess COVID-19 risk (...) should not be altered based on pregnancy status. In the UK, pregnant women should be investigated and diagnosed as per local / Public Health England 8 /Health Protection Scotland 9 criteria. Obstetricians and midwives should liaise with their local virology service / health protection team for further details about arrangements for testing and notification reporting of a positive test result. hospital is advised, pregnant women are requested to travel by private transport and alert the maternity

2020 Royal College of Obstetricians and Gynaecologists

62. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis

Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis Redirecting

2020 Covid-19 Ad hoc papers

63. Management of pregnant women with known or suspected COVID-19

Management of pregnant women with known or suspected COVID-19 Obstetric anaesthesia — ICM Anaesthesia COVID-19 Open Menu Close Menu The above guidance was commissioned from the Obstetric Anaesthetists’ Association (OAA) by the Faculty of Intensive Care Medicine, the Intensive Care Society, the Association of Anaesthetists and the Royal College of Anaesthetists. It reflects the expert opinion of senior clinicians and is based in part on published information from the current and previous (...) coronavirus outbreaks. It is correct at the time of publication but please be aware that it is subject to change as new information becomes available. We would from people as they gain experience of managing these patients. Our intention is to provide principles upon which to base the management of pregnant women with known or suspected COVID-19, but each unit will need to prepare their own detailed guidance appropriate to their setting. They will also need to liaise with services including

2020 ICM Anaesthesia COVID-19

64. Guidance for antenatal screening and ultrasound in pregnancy in the evolving coronavirus (COVID-19) pandemic

Eddie Morris, RCOG Jo Mountfield , RCOG Tim Draycott, RCOG Pat O’Brien, RCOG Ranee Thakar, RCOG Sue Ward, RCOG Jennifer Jardine, RCOG Sophie Relph, RCOG Gemma Goodyear, RCOG3 1. Introduction There are 3 antenatal screening programmes: • Sickle cell and thalassaemia (SCT) • Infectious disease in pregnancy screening (IDPS) • Fetal anomaly screening (FASP) Pregnant women with existing type 1 and type 2 diabetes should also be offered eye screening at, or soon after, their first antenatal visit (...) Guidance for antenatal screening and ultrasound in pregnancy in the evolving coronavirus (COVID-19) pandemic 1 Information for healthcare professionals Version 1: Published Monday 23 March 2020 Guidance for antenatal screening and ultrasound in pregnancy in the evolving coronavirus (COVID-19) pandemic2 Authors Matthew Jolly, NHS England & NHS Improvement Myles T aylor, BMFMS Jane Fisher, ARC Nadia Permalloo, PHE Annette McHugh, PHE Christoph Lees, Imperial College/ISUOG Pranav Pandya, UCLH/PHE

2020 Royal College of Obstetricians and Gynaecologists

65. Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)

Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Abbreviations: ABG, arterial blood gases; CDC, Centers for Disease Control and Prevention; HIV, human immunodeficiency virus. Healthcare providers should immediately notify their local or state health department in the event of a PUI for COVID-19 and should contact and consult with their local and/or state health department for recommendations on testing PUIs for COVID-19. Outpatient (...) Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Unlike influenza and other respiratory illnesses, based on a limited number of confirmed COVID-19 cases, pregnant women do not appear to be at increased risk for severe disease. However, given the lack of data and experience with other coronaviruses such as SARS-CoV and MERS-CoV, diligence in evaluating and treating pregnant women is warranted. This algorithm is designed to aid practitioners in promptly

2020 American College of Obstetricians and Gynecologists

66. Coronavirus disease 2019 (COVID-19): Pregnancy issues

Coronavirus disease 2019 (COVID-19): Pregnancy issues UpToDate It seems to us that you have your JavaScript disabled on your browser. JavaScript is required in order for our site to behave correctly. Please enable JavaScript to use our site.

2020 UpToDate

67. COVID-19 and Pregnant Patients

for COVID-19 infection for COVID-19 in pregnant patients is similar to that in the general population follow in the management of pregnant women with suspected or confirmed COVID-19 management of infection in pregnancy in women with suspected or confirmed COVID-19 there is , but supportive care may help to relieve symptoms and should include support of vital organ functions in severe cases consider of pregnant women during COVID-19 pandemic during COVID-19 pandemic unless directed otherwise by local (...) restriction all pregnant women with suspected or confirmed COVID-19 infection should receive prophylactic low molecular weight heparin upon admission to reduce risk of unless birth is expected within 12 hours for pregnancies with suspected or confirmed COVID-19 between 24 0/7 weeks and 33 6/7 weeks gestation at risk of preterm birth within 7 days, antenatal corticosteroids should continue to be offered as recommended for pregnancies between 34 0/7 and 36 6/7 weeks gestation at risk of preterm birth within

2020 DynaMed Plus

68. Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial Full Text available with Trip Pro

Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) : Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions , 127 (3), 397-403 Feb 2020 Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial , , , , , , , , Affiliations Expand Affiliations 1 Department of Obstetrics and Gynaecology, Khon Kaen Hospital, Khon Kaen, Thailand. 2

2020 EvidenceUpdates

69. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. Full Text available with Trip Pro

Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. To evaluate the associations between maternal diabetes diagnosed before or during pregnancy and early onset cardiovascular disease (CVD) in offspring during their first four decades of life.Population based cohort study.Danish national health registries.All 2 432 000 liveborn children without congenital heart disease in Denmark during 1977-2016

2019 BMJ

70. AmnioSense for unexplained vaginal wetness in pregnancy

AmnioSense for unexplained vaginal wetness in pregnancy AmnioSense for unexplained vaginal wetness in pregnancy Medtech innovation briefing Published: 26 November 2019 www.nice.org.uk/guidance/mib198 pathways Summary Summary The technology technology described in this briefing is AmnioSense. It is used for identifying leaking amniotic fluid in pregnant women with unexplained vaginal wetness. The inno innovativ vative aspects e aspects are that AmnioSense is a non-invasive test that uses a pH (...) testing and ultrasound examination of the uterus. However, these assessments are not routine practice in the NHS. P Population, setting and intended user opulation, setting and intended user AmnioSense is intended for pregnant women who have unexplained vaginal wetness. The technology is targeted towards women who are in their second or third trimester of pregnancy. The technology is designed to be used by primary and community care clinical staff or at home by pregnant women. Instructions for use

2019 National Institute for Health and Clinical Excellence - Advice

71. Pregnant Women Who Have Periodontal Disease Are at an Increased Risk for Pre-Term Birth and/or a Low Birth Weight Child

Pregnant Women Who Have Periodontal Disease Are at an Increased Risk for Pre-Term Birth and/or a Low Birth Weight Child UTCAT3410, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Pregnant Women Who Have Periodontal Disease Are at an Increased Risk for Pre-Term Birth and/or a Low Birth Weight Child Clinical Question Are pregnant women who have periodontal disease at a higher risk for having pre-term birth or low birth (...) weight children compared to pregnant women who do not have periodontal disease? Clinical Bottom Line Pregnant women who have periodontal disease are at an increased risk for having a pre-term birth (PB) and/or low birth weight (LBW) child. This association is supported by several systematic reviews looking at pregnant women with periodontal disease and the occurrence of PB and LWB. Educating women of childbearing years and preventing periodontal disease could help reduce the amount of women

2019 UTHSCSA Dental School CAT Library

72. Practice Advisory: Management of Pregnant and Reproductive-Aged Women during a Measles Outbreak

persons are at increased risk of severe illness and complications of measles 2 . The two-dose series of the measles-mumps-rubella (MMR) vaccine is safe and is 97% effective at preventing measles infection 2 . Measles Infection during Pregnancy Measles infection in pregnant women is associated with several adverse events including increased risk of hospitalization and pneumonia 3 . Measles infection during pregnancy is also associated with significant risks to the fetus 4-6 , including: Miscarriage (...) ; however, inadvertent MMR vaccination in the periconception period or in early pregnancy should not be considered an indication for termination of pregnancy 4 . Pregnancy One documented dose of MMR vaccine is sufficient for low risk individuals (including pregnant women). For people at high risk of contracting measles, a documented history of two prior MMR vaccine doses is needed to confirm immunity. However, obstetrician-gynecologists should consult their local health departments when determining

2019 American College of Obstetricians and Gynecologists

73. Continuous Glucose Monitoring in Pregnancy

Continuous Glucose Monitoring in Pregnancy Continuous Glucose Monitoring in Pregnancy - Health Technology Wales > Continuous Glucose Monitoring in Pregnancy Continuous Glucose Monitoring in Pregnancy Topic Status Incomplete Continuous glucose monitoring systems for managing diabetes in pregnant women. Summary Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of continuous glucose monitoring as an aid to managing diabetes for pregnant women. Based

2019 Health Technology Wales

74. Pregnancy and Renal Disease

to the survey, including 76 (49%) nephrologists, 36 (23%) obstetricians, 16 (10%) pharmacists, 12 (8%) midwives, 7 (4%) obstetric physicians, 5 (3%) physicians, 2 (1%) patients, 1 dietician and 1 person with role in guideline development. Of those completing the survey, 57 (37%) were part of a specialist multidisciplinary team managing women with CKD in pregnancy and 72 (46%) were routinely involved in either the renal or obstetric care of pregnant women with CKD. The strength of the recommendation (...) guidelines 19 6. Lay summary 74 7. Acknowledgements 75 Appendix 1. The experience of pregnancy and renal disease……………………………………………………………………………….76 Appendix 2. Summary of clinical responsibility for elements of the guideline 80 Appendix 3. Ovid Medline search terms (1946 to 2018) 81 Renal Association Clinical Practice Guideline Pregnancy and Renal Disease – September 2019 4 1. Introduction 1. Background Chronic kidney disease (CKD) is estimated to affect 3% of pregnant women in high-income countries

2019 Renal Association

75. Termination of pregnancy

Termination of pregnancy Maternity and Neonatal C linical G uideline Queensland Health Termination of pregnancy Queensland Clinical Guideline: Termination of pregnancy Refer to online version, destroy printed copies after use Page 2 of 32 Document title: Termination of pregnancy Publication date: April 2013 Document number: MN13.21-V3-R19 Document supplement: The document supplement is integral to and should be read in conjunction with this guideline. Amendments: Full version history (...) : Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Termination of pregnancy Refer to online version, destroy printed copies after use Page 3 of 32 Flow Chart: Summary of termination of pregnancy Queensland Clinical Guidelines: Summary of termination of pregnancy Flowchart: F13.21-1-V3-R19 Legal requirements ToP Act 2018 Less than or equal to 22+0 weeks · A medical practitioner may perform

2019 Queensland Health

76. Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care

Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care Toggle navigation Toggle search Keyword search language Keyword search Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care If you are not automatically redirected to the JOGC site within 15 seconds, please click the link above. No information available ID Access The Society of Obstetricians

2019 Society of Obstetricians and Gynaecologists of Canada

77. Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care

Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care Toggle navigation Toggle search Keyword search language Keyword search Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care If you are not automatically redirected to the JOGC site within 15 seconds, please click the link above. No information available ID Access The Society of Obstetricians and Gynaecologists of Canada (SOGC) {1} {1

2019 Society of Obstetricians and Gynaecologists of Canada

78. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer (Abstract)

Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer Current guidelines recommend that women delay pregnancy for 6 to 12 months after the receipt of radioactive iodine treatment (RAIT) following thyroidectomy for differentiated thyroid carcinoma. Although concerns exist regarding the risks associated with pregnancy after RAIT, no large-scale study, to date, has investigated the association between RAIT and pregnancy (...) outcomes.To investigate whether RAIT was associated with increases in adverse pregnancy outcomes among South Korean women who received RAIT after thyroidectomy for thyroid cancer and to evaluate the appropriate interval between RAIT and conception.This population-based cohort study used the Health Insurance Review and Assessment database of South Korea to identify a total of 111 459 women of childbearing age (20-49 years) who underwent thyroidectomy for the treatment of differentiated thyroid carcinoma

2019 EvidenceUpdates

79. Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial. Full Text available with Trip Pro

Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial. To investigate the effectiveness of routine ultrasonography in the third trimester in reducing adverse perinatal outcomes in low risk pregnancies compared with usual care and the effect of this policy on maternal outcomes and obstetric interventions.Pragmatic, multicentre, stepped wedge (...) cluster randomised trial.60 midwifery practices in the Netherlands.13 046 women aged 16 years or older with a low risk singleton pregnancy.60 midwifery practices offered usual care (serial fundal height measurements with clinically indicated ultrasonography). After 3, 7, and 10 months, a third of the practices were randomised to the intervention strategy. As well as receiving usual care, women in the intervention strategy were offered two routine biometry scans at 28-30 and 34-36 weeks' gestation

2019 BMJ

80. Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. (Abstract)

Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. The safety, efficacy, and appropriate timing of isoniazid therapy to prevent tuberculosis in pregnant women with human immunodeficiency virus (HIV) infection who are receiving antiretroviral therapy are unknown.In this multicenter, double-blind, placebo-controlled, noninferiority trial, we randomly assigned pregnant women with HIV infection to receive isoniazid preventive therapy for 28 weeks, initiated either during (...) pregnancy (immediate group) or at week 12 after delivery (deferred group). Mothers and infants were followed through week 48 after delivery. The primary outcome was a composite of treatment-related maternal adverse events of grade 3 or higher or permanent discontinuation of the trial regimen because of toxic effects. The noninferiority margin was an upper boundary of the 95% confidence interval for the between-group difference in the rate of the primary outcome of less than 5 events per 100 person

2019 NEJM